4//SEC Filing
Gibbs Michael Terrence 4
Accession 0000950170-23-010276
CIK 0001492674other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:02 PM ET
Size
6.6 KB
Accession
0000950170-23-010276
Insider Transaction Report
Form 4
Gibbs Michael Terrence
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2023-03-24+333→ 6,850 total - Exercise/Conversion
Restricted Stock Units
2023-03-24−333→ 0 total→ Common Stock (333 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]On March 24, 2020 the reporting person was granted 1,000 RSU's that vest in three equal annual installments commencing on March 24, 2021.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001665000
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 4:02 PM ET
- Size
- 6.6 KB